The Legatum Institute's Prosperity Index goes a long way toward addressing shortcomings in other measurements of people's well-being around the world.
For prosperity in Africa, what is needed is a holistic approach that focuses on the building blocks that empower Africans to help themselves.
The Legatum Institute's Prosperity Index helps answer the question of how to promote prosperity in Latin America.
According to the Legatum Index, although Australia is very strong on the economic fundamentals required for long-term growth, problems in the health care system are keeping the country from reaching its full potential, in terms of both economic progress and quality of life.
Gross domestic product (GDP) is not a sufficient measurement of prosperity, but the Legatum Institute's Prosperity Index addresses some of the shortcomings of the GDP by measuring a variety of economic and social indicators for people around the world.
India ranked forty-fifth to China's seventy-fifth on parameters of wealth and well-being.
Wellcome Trust
October 26, 2009
Myriad responses are required for all parts of the substandard drug problem.
There are many indicators of solid data that can help us broaden measures of well-being far beyond GDP.
Awarding President Obama the Nobel prize, while shocking to many, is merely the logical extension of European, particularly Nordic/Scandinavian, policy for at least the last two decades: as long as one appears to care and says the right things, it does not matter if you do anything useful.
The Indian government is touting a new survey showing a low percentage of drugs within the country are counterfeit. But the reality is that India still has a major problem will poor-quality drugs.
Unless philanthropists insist on market principles in Africa's drug market, and until they apply necessary due diligence when cutting checks, their aid stands to be hijacked by governmental opportunism, incompetence, and corruption.
It is likely that some form of drug reimportation will be approved by the U.S. Congress this year, if not in the next few weeks.
Fake drugs flourish in areas where government oversight is poor and private-sector accountability is weak, but failing to prevent counterfeit drug sales can have deadly consequences.
The donor community and governments are jeopardizing lives through their push for local production.
Many Africans lack access to essential medicines for myriad reasons, including the relatively high price of drugs: local production is unlikely to alleviate this problem.
The donor community indirectly and African governments directly are undermining drug quality through their push for local production.
Institute of Economic Affairs
August 24, 2009
The UN's push for a "zero DDT world" ignores the millions of lives DDT has saved over the past century with little-to-no adverse environmental impact and no harm to human health.
This study examines the price, conditions of purchase, and basic quality of five popular drugs purchased over the Internet.
Purchasing drugs over the Internet has significant benefits, but it can also be dangerous.
While safety concerns about drugs purchased over the Internet may be overblown, concerns that the equalization of drug prices will decrease drug innovation are understated.
Buying drugs online may not be as dangerous as you think.
For at least three decades, Nigeria has been plagued by counterfeit and poor quality medicines, but today it offers a rare model of improvement.
An informal survey of doctors, pharmacists, health care workers in Lagos, Ondo, and Ogun, and a pilot quality assessment of essential drugs from Lagos pharmacies.
Turkish-made pharmaceutical products are generally of high quality, but significant trade flows allow unscrupulous suppliers greater opportunity to provide substandard products to the market.
Recent court decisions in India endanger drug investment.
The revitalization of the political and think tank culture in Britain is vital or there is a risk of more of the same when David Cameron inevitably wins office next year.
Cricket and baseball are twin brothers, separated at birth.
The drive to combat counterfeit drugs is a good one, but there are problems with Kenya's legislation and the pending legislation in Uganda, which could have serious implications for the importation and production of generic drugs.
There are always costs of both action and inaction; however, before a costly scheme is funded, better evidence of its effectiveness should be established.
The drug regulatory system in India needs to be improved for domestic consumption and because India is an increasingly important exporter of drugs for both developed and developing countries.
Ranbaxy's run-in with the FDA illustrates problems in developing-world drug production, but is there a place for less stringent quality standards?
Drug importation would harm Americans' health and jeopardize future developments in medical science.
Michela Wrong's new book highlights a key problem: corruption can undermine democracy.
Government agencies, the pharmaceutical industry, and humanitarian organizations must work together to stamp out counterfeit drugs.
More than 1 billion people on Earth live without access to clean water.
The United Nations plans to advocate drastic reductions in the use of DDT, which kills or repels the mosquitoes that spread malaria.
Illegally copying a trademark is an important indicator of counterfeiting, although not necessarily of substandard drug quality.
A recent case reveals that it is not only generic firms from middle income countries that have problems with good manufacturing practice.
The majority of the antimalarial products on sale in Kenya are neither brands nor generics but copy products of unknown provenance and variable quality.
New technologies can help African countries identify counterfeit or substandard drugs.
DDT is a proven effective anti-malaria measure, but the United Nations has abandoned science for the sake of political correctness.
The counterfeit drug trade is a problem that Beijing can cure.
How to give Zimbabwe the boost it needs without propping up Robert Mugabe.
Americans have for many years been paying the world's highest prices for pharmaceuticals--but is it more than their fair share?
Why do rich nations elect to fund global health campaigns to tackle problems with no supra national element at all, such as obesity or smoking?
China, a major link in the world's pharmaceutical supply chain, is taking steps and forming international partnerships to improve drug safety and combat drug counterfeiting.
Regional and local officials are taking the initiative to stop the deadly and odious trade of counterfeit and substandard drugs in India.
Extending expiration dates is the cheapest remedy for the world's most prevalent epidemic.
Many deaths that occur from malaria each year could be avoided if antimalarial drugs were effective, of good quality, and used correctly.
Every anticapitalist and antiglobalisation group is represented in London with myriad dangerous demands.
Zimbabwe can take a page out of Liberia's playbook.
Several European nations are turning away from vaccination and are now spreading disease.
India's major pharmaceutical companies and its public health community want to establish a modern drug regulatory system.
Malaria is becoming increasingly resistant to even the most modern drugs--largely due to badly made or counterfeit medicine.
The Food and Drug Administration has very real shortcomings. But is new regulation the best solution?
Many aid groups who purchase generic drugs for developing countries do not require evidence of bioequivalence.
Can the shelf-life of fixed dose combination artemether-lumefantrine be extended?
There is new hope in Zimbabwe, or at least that is what everyone wants to believe.
To sustain the fight against insect-borne diseases, we must improve research funding for public health insecticides.
The World Health Organization's anti-counterfeit drug task force should broaden its scope to fight the scourge of substandard pharmaceuticals.
It is time for Chinese authorities to boost the independence and transparency of their legal system.
Substandard drugs put the health of millions at risk. More needs to be done to increase safety standards.
Zimbabwean president Robert Mugabe does not recognize any African authority.
Africa's leaders have helped Robert Mugabe remain in power.
Africa Fighting Malaria is calling on the WHO, donor agencies, and other stakeholders to provide more investmentfor insecticides.
Economic Affairs
December 12, 2008
The EU's new regulations on pesticide use are designed to protect public health. But they could end up harming it instead.
Zimbabwe's kleptocrats are at war with their own people.
Abuse of the tort system by trial lawyers is driving safe drugs from the market and patients from mainstream medicine.
Despite all its good work, the Gates Foundation is encouraging a harmful trend among malaria activists.
The cholera epidemic in Zimbabwe may be spreading to other African nations.
Today, cholera can easily be controlled by maintaining simple sanitary standards--but there is no running water in much of Zimbabwe, and sanitation systems have collapsed.
Recently approved legislation should help India in its battle against substandard pharmaceutical products.
The proliferation of low-quality and counterfeit drugs is one of the most pressing problems in delivering life-saving medicines to the world's poorest patients.
What can the world do to help Zimbabwe?
Ranbaxy continues to supply the developing world with drugs that are not checked for quality.
To motivate businesses to ensure product safety and thus encourage durable growth, China must allow free news media and courts that uphold the law instead of the status quo.
Fake drugs kill thousands of people each day, thanks to counterfeiters in China and India who mix chalk, dust, and dirty water into pills sold around the world.
A new global subsidy to give malaria patients the best treatment may divert money from simpler campaigns and could undermine drug quality.
Beijing has a major problem with food contamination. The British solved a similar dilemma in the 1800s.
As Beijing attempts to address the latest food scandal to rock China, countries around the world are demanding action to prevent the spread of contamination.
Ranbaxy continues to supply the developing world with drugs that are not checked for quality.
President Mugabe's military backers refuse to give up any real power, jeopardizing the recently signed power-sharing agreement.
Chinese officials are scrambling to save children's lives from its latest food scare--contaminated milk products.
AEI Online
September 18, 2008
Aid agencies, advocates, and national governments have a responsibility to ensurethatbillions of dollars inpharmaceutical procurementare spent on safe, effective, life-saving drugs.
To stem the contamination crisis, Chinese officials should be giving handheld spectrometers to their key regulators.
Economic Affairs
September 18, 2008
Why doesBeijing have so much troublestopping the exportation of dangerous drugs?
What can thenew government of Zimbabwe do about the economic devastation plaguing the country?
The debate over patent breaking in Thailand comes to Capitol Hill.
India is a center for drug counterfeiting, a deadly business that is spreading to the United States and Europe.
Olympic visitors might consider steering clear of military-owned hospitals where they could run the risk of being treated with substandard or counterfeit medicines.
Afghanistan has made undeniable progress on public health. But will it be sustainable?
The United States and the European Union need to make sensible policy changes to reduce the likelihood of future counterfeit drug tragedies.
The global health community must strengthen its commitment to protect patients from poor-quality medicines.
While the international community, the African Union, and Zimbabwe's neighbors may not be able to stop Robert Mugabe, the economy might.
Beijing is taking Draconian measures to clean up for the Olympic Games starting next month.
Billionfold inflation may do to Robert Mugabe what he would not allow Zimbabwean voters to do: end his rule.
As the British military drafts plans for humanitarian intervention, all eyes are on Zimbabwe's neighbors.
Openness to trade and higher volumes of trade can have positive health benefits.
Most anti-malarial drugs are obtained in the private sector and few of the widely discussed drugs are actually bought by most Africans.
Regime change in Zimbabwemay be only a few weeks away.
Robert Mugabe's apologists--including the former Mozambican president--are helping to keep alive his odious regime.
Zimbabwean president Robert Mugabe continues to threaten anyone who will vote against him in next week's elections.
DDT had come under fire from larger corporations and environmentalists. But it is saving lives in Southern Africa.
Openness to trade and higher volumes of trade can have positive health benefits.
Counterfeit pharmaceuticals in Southeast Asia could pose a serious global health risk.
In Africa and Southeast Asia, drugs successfully used for years to combat malaria, tuberculosis, and HIV are failing more and more often.
Drugs purchased by government aid agencies and NGOs using taxpayer dollars are often substandard and dangerous.
New research indicates that many drugs bought by developed-world governments and NGOs fail crucial quality tests.
The high persistence of substandard drugs and clinically inappropriate artemisinin monotherapies inAfrica risks patient safety and endangers the future of malaria treatment.
The new Thai government is following the path of its predecessors, breaking drug patents and not spending enough on health.
New Delhi has a dodgy record on safeguarding intellectual property rights. Here is how it could improve.
Malaria country governments, donors, UN agencies, and advocates should focus on policy reforms needed to achieve sustained improvement in malaria treatment outcomes in Africa.
Drug regulation in China needs to be enforcedin order to prevent fatalcontaminants.
The recent heparin case illustrates that the high cost of health care cannot be combatted with the importation of cheaper drugs, many of which are risky andineffective.
AEI Online
April 24, 2008
Forthirty years, the fight against malaria has been long on rhetoric and short on action. But for the first time since the 1960s, malaria is being fought effectively on a global scale.
Rolling back the insect-borne disease will require better coordination between aid agencies and private companies.
Multilateral organizations in conjunction with the FDA must do more to expose the problem of counterfeit drugs and help countries tighten regulatory controls.
To stay inpower, Robert Mugabe has a German company printing worthless bank notes to bribe officials in the public sector, army, and other public-security servicesin Zimbabwe.
Members of the World Health Organizationare blamingthe spreadof malaria on global warming when the real culprit was modern transportation.
Members of the World Health Organizationare blamingthe spreadof Malaria on global warming; however, diseases are not restricted to certain climates and poor countries.
The government's lack of spending on health care in Thailand is a scandal and it is furthered by their high drug prices.
Members of the European Parliament are against the use of pesticides, but also want to stop the spread of malaria.
If patent laws are thrown out in India's high court, it could jeopardize the world's patent system.
Hopefully Thailand’s patent fight will increase global awareness on the replication of branded drugs.
Permitting slightly higher drug prices today will guarantee incentives for innovation and development tomorrow.
A new proposal from the United Nations would alter the traditional role of drug companies and governments, leading to fewer drugs for developing world diseases.
The Gates Foundation has been a massively positive influence on malaria research, but it is still criticized.
As aid agencies vacillate, the crisis in East Africa is getting worse.
Zimbabwe has been enduring a crisis without a great deal of political support, but there is hope that a new regional leadership will address the current issues.
The distribution of prescription drugs is a major issue in world politics because the cost of drugs is preventing access to treatment.
AEI Online
February 1, 2008
Production of pharmaceuticals in developing countries can promote growth--but only when the market prescribes it.
When the research-based pharmaceutical industry gives up investing in innovation, where will new medicines come from?
The cost of corruption is visible today in Thailand and Kenya.
AEI Online
January 1, 2008
Africa has received far more health aid than ever before, but the results have been generally disappointing and occasionally even counterproductive.
African nations have to be much more transparent in their health systems work in order to stamp out corruption.
Counterfeit and substandard pharmaceuticals are a massive problem, and international bodies need to confront them head-on.
How should we price life-saving drugs? Not the Oxfam way.
Researchers and pharmacologists around the world are working on new drugs, but their efforts are complicated by the murderous opportunists who fake legitimate products.
It may be time for drug companies to invest only in countries that truly protect intellectual property rights.
Local production is not necessarily the answer to pharmaceutical shortages in Africa.
Though DDT has proven to control malaria better than any other intervention, opposition to its use continues to mount.
Improving hygiene in hospitals is a cost-effective way to save lives and avoid lawsuits.
AEI Online
November 5, 2007
DDT has been more effective against malaria than any other intervention, but inaction and political hostility may halt its recent renaissance.
How many more must die of malaria for no good reason?
Activist groups should join together in support of an anti-malaria insecticide that could save millions of lives.
How many more must die of malaria for no good reason?
In attempting to ban pesticides, policymakers are overlooking the risk of insect-borne diseases.
Martin Meredith's new book offers a painful look at the formation of modern South Africa.
When good medical journalism exposes abuses at international health NGOs and governmental organizations, public health benefits.
As the Gates Foundation meets this week, it should take a closer look at the "global subsidy" campaign.
AEI Online
October 10, 2007
Dirty hospitals, unsafe blood, and widespread use of injections make health care dangerous, in both developed and developing countries.
How Robert Mugabe ruined his country, and what the world can do about it.
Why ignore theWorld Health Organization's medical advice?
The business of counterfeit medicines is exploding, and it is killing poor Africans.
The World Health Organizationhas just endorsed medicines that havenotpassed muster with western regulators.
An on-the-ground report on how malaria control is going in Uganda.
The health service, like the entire country, requires rescuing from the murderous hands of Robert Mugabe.
AEI Online
August 9, 2007
Differential pricing is necessary to provide suffering people in poor countries access to needed medicines and ensure that medical innovation will continue in the future.
Australia's water management is still leading the way, even in drought.
A discussion of world water markets and various countries' water policies.
What if Muslim clerics were held to the same standards as Pfizer?
Many malaria sufferers are receiving unsafe, low-quality drugs. The FDA and the Global Fund must act to change this.
Counterfeit and substandard medicines are a huge roadblock for global health, so why do large NGOs not do more to stop them?
The developed nations are happy to send aid, but reluctant to ask uncomfortable questions.
To make people healthier, new World Bank president Robert Zoellick should step back and let other organizations take the lead.
Whenever the Thai government defiesforeign drug patents and creates its own cheap copies of drugs, it endangers the patients who need the drugs and undermines drug discovery.
Rachel Carson was a progenitor of the environmental movement, and she should share some of the blame, as well as the praise, forits impact.
It may be everywhere, but it is scarce as well.The solution of efficient water use can be found in a nation undergoing the worst drought in 1,000 years: Australia.
A recentvote putting Zimbabwe in charge of the UN Commission on Sustainable Development does not make it any easier to take the body seriously.
The World Health Organization used to be effective in eradicating diseases, but pointless targeting and kowtowing to political correctness have harmed global health.
Grand goals will only help world health if they can be measured--and achieved.
The malaria community cannot remain silent in the face of attacks against the use of DDT.
A tiered model--based on ability to pay--is best, but will only work if the industry stands up for itself.
Prospects for malaria control are now brighter than they have been in decades.
Funding for malaria control has increased significantly over the past decade, but it is still unclear whether that funding is actually saving lives.
India is at a crossroads. It can follow the route it has taken in software engineering, or it can travel the opposite route with idiosyncratic rules that limit growth and innovation.
An interview with Roger Bate about the World Bank, the IMF, and the Wolfowitz scandal.
Under what circumstances should compulsory licensing for drugs be used?
The Thai government is breaking patents on Western drugs, but such actionwill haveconsequences for theThailand,afflicted patients, and global health.
Thailand's government is breaking Western pharmaceutical patents--not for health reasons, but for its own financial gain.
The Global Fund to Fight AIDS, Tuberculosis, and Malaria will only be as effective as its procurement process allows.
AEI Online
March 23, 2007
Problems with procurement, corruption, and intellectual property threaten new and innovative malaria treatments.
Eradicating corruption from the health sector through the removal of tariffs is vital.
A brave band of reformers is taking on Kenya’s endemic culture of corruption.
Innovation by India's internationally competitive scientists suffersfrom the Indian government'sprotectionist policies.
Countries seeking toaid Liberia should focus on pressing problems and not their own pet projects.
Help for medicinal innovation in Thailand is coming from an unlikely source.
A new initiative by Senator Tom Coburn could bringtransparency to the Global Fund to Fight HIV/AIDS, Tuberculosis, and Malaria.
As thecost of drug development continues to rise, patent wars in Asia threaten to weaken efficient pricing.
As Thailand overrides patents on foreign drugs, the only winner will be the government.
AEI Online
February 7, 2007
India is at a crossroads: it can protectintellectual property orlimit growth and innovation.
India has a choice: itcan either follow the route it has taken in software engineering or it can travel the opposite route with idiosyncratic rules that limit growth and innovation.
AEI scholars respond to the State of the Union address.
Efforts to improve global health are often crippled by a state of denial.
Given the poor track record of foreign aid in developing countries, simply sending more aid would be counterproductive unless drastic changes are made.
Many more lives could be saved with indoor residual spraying using DDT as part ofa malaria control program.
With little fanfare, businesses are trying to fight disease in Africa. The best spur to benevolence: the profit motive.
USAID is still charged with prioritizing Western values in foreign policy as well as meeting humanitarian need, yet its mission in health has often been obscured.
Gaddafi's blameshifting on AIDS in Libya exposes how many African countries try to cover up their failures by blaming the very countries that wish to help them.
There is no doubt the Global Health Bureau of the U.S. Agency for International Development is moving foreign assistance in the right direction.
AEI Online
December 13, 2006
To make essential drugs available to needy patients in poor countries, those countries need to take down their trade barriers.
Global health depends as much on the participation of people in impoverished countries as it does on philanthropic Western donors.
USAID's approach to fighting malaria by building in-country capacity to control malaria will be the true test of its reforms moving forward.
Another World AIDS Day has arrived today and, although hard to believe, the situation across the globe is worse than before.
AEI Online
November 30, 2006
Over 1.6 million people in the poorest parts of the world are now on antiretroviral treatment to halt the advance of HIV, but in a rush to improve access, mistakes have been made.
Health care is taking up more and more of government budgets globally, and corruption is probably rising faster in health care than almost any other sector.
Excessive tariffs on essential medicines hurt global health.
Debates about which tools and strategies work best against malaria are fraught, but there are some things that can be agreed upon.
The World Bank's malaria program does not appear to comply with the World Health Organization's technical guidelines.
The World Bank should stick to its core mission of funding health systems and get out of the disease control business.
AEI Online
October 2, 2006
The South African health minister defends her country's record on HIV/AIDS prevention and treatment.
Tragically, the World Bank’s mishandling of scientific issues has serious consequences--consequences that kill patients.
As much of Asia struggles with water shortages, Australia’s agricultural sector is thriving, despite its worst drought in decades.
By maintaining the dogma of South African failure, U.N. officials such as Stephen Lewisdeflect attention from other AIDS actor’s mistakes and contribute to the perpetuation of poor policy.
It would be tragic if Afghanistan's future leaders were more worried about keeping its aid donors happy than pleasing its electorate.
Arid countries should adopt Australia's water trading policies.
Leaders of developing countries should not wait for U.S. and EU action, but should restart the Doha Development round by taking the simple, initial step required to help their own people--implementing national tariff policies that eliminate tariffs and taxes on essential medicines.
Advocates the bill for a new Federal Funding Accountability and Transparency Act requiring the government to maintain a single public website listing the names and locations of all individuals and groups receiving federal funds.
The world’s largest countries face future water crises, but Australia points the way forward in water property rights.
AEI Online
August 4, 2006
How do regulatory barriers restrict access medication in developing countries?
With Warren Buffett’s largesse added to his own, Bill Gates has about $60 billion to spend on health and development. How should he spend it?
Alarmists have been crying wolf about water wars for years, but like many green exaggerations they have a kernel of truth.
The Bill and Melinda Gates Foundation should be commended for supporting HIV and malaria clinical research. However, it has avoided dirtying its hands by staying away from on-the ground interventions.
Developing countries claim the West cheats them out of cheap drugs. But they are often the ones erecting barriers to their citizens’ health.
Is property right protection vital for development and conservation in Zimbabwe and the rest of Africa?
The most important U.S. aid vehicle, the United States Agency for International Development (USAID), has failed disastrously in its mission.
The world’s poor and those in need of medicines would be better off if the WHO took different approaches to pharmaceutical development.
The World Bank is failing miserably on malaria, like it failed on HIV/AIDS before.
What can the World Health Organization and the World Bank to do avoid mission creep?
Testimony to thePresident’s Advisory Council on HIV/AIDS (PACHA), the first part emphasizing the strainrelated to tariffs on medicines, markups and access to essential medical interventions and the second part regarding mission creep in aid agencies.
A review of William Easterly's The White Man's Burden.
AEI Online
April 25, 2006
How has mission creep affected the World Health Organization's and World Bank's efforts to combat malaria?
How will the World Bank's new plan help combat malaria?
In a new Lancet paper my colleagues and I point out that the World Bank has failed in its anti-malaria program. So what now?
Provision of healthcare in China and Asia has failed to keep pace with economic growth and environmental strain.
Having successfully incorporated market forces into other areas of its booming economy, it's time to extend the same approach to the environment.
A review of Sebastian Mallaby's The World's Banker.
How are HIV and AIDS affecting the population of Sierra Leone?
What can the average Joe do to help fight malaria?
In the time it takes you to read this column, at least ten people in poor countries will die from diseases that are preventable and curable.
In the time it takes you to read this column, at least ten people in poor countries will die from diseases that are preventable and curable.
Ensuring that there are profits to be made from HIV/AIDS is probably the best way to keep companies investing and researching.
Provision of health care in developing regions is not keeping pace with rapid economic growth.
Although aid has increased in recent years and the price of many drugs has fallen, worldwide access to medicines, vaccines, and medical devices has not kept pace.
Will Paul Wolfowitz really improve World Bank's performance as co-sponsor of the Roll Back Malaria campaign?
AEI Online
February 16, 2006
The main obstacle to access for essential medicines is the high tariffs that poor countries impose on medicines and medical devices.
International funders must take a broader focus on the needs of the country where they lend money--or accept that their largesse may backfire.
AEI Online
January 19, 2006
The WHO initiative to treat 3 million HIV-infected people in low- and middle-income countries by the end of 2005 (popularly known as the “3 by 5” initiative) has failed.
As 2006 unfolds, promises of bringing life saving interventions against malaria must be kept and all funds pledged must be accounted for.
President Bush and USAID must be commended for being the first to explicitly mention funding spraying programs.The tools to protect millions of lives are at our fingertips.
Bad policy contributing to rampant AIDS has become the master narrative of much western reporting on South Africa. But the tide has turned and there is progress to report.
While East–West security relations are no longer of concern, Iceland is still a useful location to bring the EU and USA together on thorny issues that might be leading to a transatlantic rift.
AIDS Institute Conference
December 14, 2005
I will be talking about one means by which access issometimes entirely prevented--by the imposition of taxes and tariffs on medicines and medical devices in many countries of the world.
AEI Online
December 12, 2005
Poor nationsshould reject theanti-intellectual property and anti-pharmaceutical company stance that, in a resource-poor setting, is unlikely to be helpful ineither the shortor long terms.
Aspen Institute
December 8, 2005
At a recent trade conference I was astonished to see a poster with the words “Aid not Trade.” As though the two were mutually exclusive.
Hedge Funds v. Malaria Conference
December 6, 2005
I hope you will leverage your efforts by supporting our various campaigns to get major donors like USAID to spend their money, our taxpayer money, effectively.
Congress must cut low-priority spending and wasteful programs--such as broken international aid programs--to offset the new financial burden our nation faces.
The World Health Organization's target of treating three million people infected with HIV/AIDS by the end of this month has failed by about two thirds.
The World Health Organizationhas an important role as a purveyor of information and as an urgent responder to international concerns, butit iscounterproductive in so many of its roles.
Sasol has developed a viable partial solution to the carbon dioxide/climate conundrum and has providedsome of the cleanest fuels on the market.
The country’s expertise in gold and diamond mining is well known, but its success with fuel technologies is now gaining respect and recognition.
If the Bush administration shifts USAID to buying malaria-preventing commodities, especially DDT, real success is possible.
Congress is about to appropriate $105 million for malaria control, and the money will be wasted--yet again.
Sunday Independent
October 16, 2005
What is the point of development aid to a region that will condone mass murder and the wholesale theft of property rights?
The Weekly Standard
October 3, 2005
A review of Martin Meredith's The Fate of Africa: From the Hopes of Freedom to the Hearth of Despair; A History of Fifty Years of Independence (PublicAffairs, 2005).
There can be few more compelling and tragic examples of the abuse of science and misuse in ongoing public policy than that of DDT and public health.
Institute of Economic Affairs
September 27, 2005
Environmental policies that banned the only viable form of protection against locusts have caused direct harm in Niger.
Business Day
September 20, 2005
It is essential that the US provide more humanitarian relief, push the United Nations to help, and support civil society. Violent conflict will be the result unless more external aid is provided.
Wall Street Journal
September 16, 2005
Let us hope that Americans don’t believe everything they see at the movies.
Economic Affairs
September 1, 2005
The real reason that Zimbabwe has collapsed is that there is no protection of private property. The result is "dead capital" and total economic annihilation.
The United States and Britain must announce that African Union deliberations on access to the Security Council are meaningless untilAU deals with its own countries’ human rights problems.
Mont Pelerin Society
August 24, 2005
Liberty, sound science, and property rights provide the answers for African development.
South Africa finally shifts to deal with Zimbabwe PresidentRobert Mugabe as inflation skyrockets.
By promoting a treaty banning an insecticide, green alarmists contributed to the drought in Niger they now pin on global warming.
Marshall Institute of Science and Public Policy Roundtable
August 2, 2005
The G8 summit was momentous. Its headlines managed to compete with the terrorist attack in London, andof thefew concrete agreements made, most were a triumph for U.S. diplomacy.
Zimbabwean president Robert Mugabe has destroyed his country; now he isbegging the Chinese for money.
Daily Standard
August 1, 2005
Chinese investment in Africa appears to be about both politics and business, with the latter holding sway, at least when it comes to Zimbabwe.
By pushing a treaty banning insecticides, green alarmists created a tragedy in Niger they now blame on global warming.
Daily Standard
July 27, 2005
China's involvement in Zimbabweis economically astute, but itswillingness to take over the economic means of production in a pariah state is politically worrying.
Daily Standard
July 26, 2005
By inviting Kofi Annan to visit, Robert Mugabe has presented Annan with an opportunity to reestablish the reputation of the United Nations.
Tech Central Station
July 21, 2005
The longer-term threat is that in the face having their drugs effectively confiscated, Abbott will cut back on research and development of drugs whose main markets are in developing countries.
Up to 1.5 million people homeless, more than 300,000 homes destroyed, more than 46,000 people arrested, over 4 million people starving.
The Weekly Standard
July 18, 2005
Review ofJeffrey D. Sachs's The End of Poverty: Economic Possibilities for Our Time.
Economic Affairs
July 18, 2005
Review of Michael Crichton's State of Fear.
Daily Standard
July 13, 2005
The realization that boys growing up in West Yorkshire could kill overfifty of their countrymen with almost military precision and fanatical determination has rocked this most stoical of nations.
Daily Standard
July 11, 2005
In essence, the G-8 went for the low-hanging fruit. It is easy to write checks, but far more difficult to change the policies that create poverty.
Africa Fighting Malaria
July 8, 2005
As the G-8 negotiations enter their final phase there appears to be no deal on agricultural subsidies or climate change; France's proposalsarepotentially disastrous for global economies.
Daily Standard
July 8, 2005
Chancellor Schröder or President Chirac have an opportunity to show solidarity, and they should not blow it.
Tech Central Station
July 7, 2005
It’s not the people of UK and United States that need to be paying attention, but those in France and Germany. It's time to wake up--Paris and Berlin may well be next.
Africa Fighting Malaria
July 7, 2005
The resolution to the G-8meeting is going to come down to two major compromises--France on agricultural subsidies and the United States on climate change.
Africa Fighting Malaria
July 6, 2005
African businessmen seem intent on telling G8 leaders that the way to help Africa is to allow it to help itself, since aid is no long-term solution.
Africa Fighting Malaria
July 6, 2005
Robert Mugabe remains president of Zimbabwe only through corruption of the democratic process and the legal system and through suppression of opposition.
Africa Fighting Malaria
July 4, 2005
Reportingfrom the African Union's meeting in London days before the G-8 Conference.
Committee on International Relations Subcommittee on Africa, Global Human Rights and International Operations
July 1, 2005
Poverty will not be made history by aging rock stars and good will, but by sound institutions and domestic growth. Aidcan be counter-productive if not done carefully.
Tech Central Station
June 27, 2005
Only those who want fewer HIV drugs can welcome Brazil's actions; everyone else should be worried.
The Weekly Standard
June 27, 2005
When will Mugabe's neighbors, as well as the United States and the United Kingdom, intervene? By the end of this year, Mugabe may be well on his way to halving his population.
Medical Progress Today
June 23, 2005
Health and wealth are intimately co-dependent, andthe professionals have no excuse not to recognizethe value of free trade, especially to developing countries.
American Conservative Union
June 21, 2005
The saber rattling has to stop or the current deliverers ofHIV drugswill have left the business.
Tech Central Station
June 20, 2005
If the East African trade ministers meeting today care about their people, rather than the narrow interests of theirpharmaceutical industry, they should all agree to tariff removal.
EMAIL
PRINT
SAVE
